You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

654 Results
Le Programme de radiothérapie vise à assurer l’accès au moment opportun à des traitements de radiothérapie sécuritaires de haute qualité et fondés...
Document
New
Jan 2025
Guidelines and Advice
Status: Current
ID: MOTAC-7
Updated
Jan 2025
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - First-line Treatment of Advanced HER2-negative Esophageal, Gastric, and Esophagogastric Junction Carcinoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jan 2025
Drug
Other Name(s): Vectibix®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jan 2025
Drug
Other Name(s): Trecondyv®
Quick Link(s): Drug Monograph
Jan 2025
Drug
Other Name(s): Keytruda®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jan 2025
Drug
Other Name(s): Tukysa™
Quick Link(s): Drug Monograph, Patient Info Sheet
Feb 2025
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
pirtobrutinib (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Feb 2025
Regimen
Cancer Type:
Lung, 
Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
tarlatamab (Compassionate)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Feb 2025
Family physicians, nurse practitioners and nurses play a crucial role in cancer care, greatly influencing patients' participation in cancer screening...

Pages